Scholar Rock Holding (SRRK) Total Debt (2017 - 2026)
Scholar Rock Holding's (SRRK) quarterly Total Debt came in at $196.6 million in Q1 2026, up 295.28% year-on-year from $49.7 million in Q1 2025, and up 97.19% quarter-over-quarter from $99.7 million in Q4 2025.
Scholar Rock Holding (SRRK) Total Debt (2017 - 2026) Analysis & Trends
Scholar Rock Holding's Total Debt history runs 10 years deep, the most recent figure standing at $196.6 million for Q1 2026.
- On a quarterly basis, Total Debt rose 295.28% year-over-year to $196.6 million in Q1 2026; TTM through Mar 2026 was $196.6 million, a 295.28% increase from a year earlier, with the FY2025 full-year figure at $99.7 million, up 98.84% from the prior year.
- Total Debt grew to $196.6 million in Q1 2026 per SRRK's latest filing, from $99.7 million in the prior quarter.
- Across five years, Total Debt topped out at $196.6 million in Q1 2026 and bottomed at $49.7 million in Q1 2025.
- The 5-year median for Total Debt is $50.1 million (2024), against an average of $64.5 million.
- Across the five-year window, Total Debt retreated 1.21% in 2023 and soared 295.28% in 2026, its largest moves.
- Year by year, Total Debt stood at $49.7 million in 2022, then gained by 0.55% to $50.0 million in 2023, then rose by 0.26% to $50.1 million in 2024, then jumped by 98.84% to $99.7 million in 2025, then soared by 97.19% to $196.6 million in 2026.
- Per Business Quant, the three latest SRRK Total Debt figures stand at $196.6 million (Q1 2026), $99.7 million (Q4 2025), and $100.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 959.06 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Scholar Rock Holding | 6.30 Bn | 6.30 Bn | - | 196.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 196.61 Mn |
| Dec 31, 2025 | 99.71 Mn |
| Sep 30, 2025 | 100.00 Mn |
| Jun 30, 2025 | 49.76 Mn |
| Mar 31, 2025 | 49.74 Mn |
| Dec 31, 2024 | 50.15 Mn |
| Sep 30, 2024 | 50.10 Mn |
| Jun 30, 2024 | 50.07 Mn |
| Mar 31, 2024 | 50.10 Mn |
| Dec 31, 2023 | 50.02 Mn |
| Sep 30, 2023 | 49.96 Mn |
| Jun 30, 2023 | 49.90 Mn |
| Mar 31, 2023 | 49.83 Mn |
| Dec 31, 2022 | 49.74 Mn |
| Sep 30, 2022 | 50.57 Mn |
| Jun 30, 2022 | 50.39 Mn |
| Mar 31, 2022 | 50.20 Mn |
| Dec 31, 2021 | 50.00 Mn |
| Sep 30, 2021 | 24.93 Mn |
| Jun 30, 2021 | 24.85 Mn |